Teva Pharmaceutical Industries Ltd (TEVA)
16.26
+0.26
(+1.59%)
USD |
NYSE |
May 10, 16:00
16.28
+0.02
(+0.15%)
After-Hours: 20:00
Teva Pharmaceutical Industries Price to Book Value: 2.530 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.49 |
| May 08, 2024 | 2.450 |
| May 07, 2024 | 2.171 |
| May 06, 2024 | 2.188 |
| May 03, 2024 | 2.176 |
| May 02, 2024 | 2.191 |
| May 01, 2024 | 2.176 |
| April 30, 2024 | 2.186 |
| April 29, 2024 | 2.194 |
| April 26, 2024 | 2.149 |
| April 25, 2024 | 2.062 |
| April 24, 2024 | 2.025 |
| April 23, 2024 | 2.025 |
| April 22, 2024 | 2.004 |
| April 19, 2024 | 2.001 |
| April 18, 2024 | 1.989 |
| April 17, 2024 | 2.051 |
| April 16, 2024 | 2.037 |
| April 15, 2024 | 2.059 |
| April 12, 2024 | 2.070 |
| April 11, 2024 | 2.158 |
| April 10, 2024 | 2.155 |
| April 09, 2024 | 2.174 |
| April 08, 2024 | 2.210 |
| April 05, 2024 | 2.218 |
| Date | Value |
|---|---|
| April 04, 2024 | 2.168 |
| April 03, 2024 | 2.197 |
| April 02, 2024 | 2.157 |
| April 01, 2024 | 2.165 |
| March 31, 2024 | |
| March 28, 2024 | 2.107 |
| March 27, 2024 | 2.155 |
| March 26, 2024 | 2.112 |
| March 25, 2024 | 2.100 |
| March 22, 2024 | 2.074 |
| March 21, 2024 | 2.054 |
| March 20, 2024 | 2.013 |
| March 19, 2024 | 1.994 |
| March 18, 2024 | 1.989 |
| March 15, 2024 | 2.006 |
| March 14, 2024 | 2.016 |
| March 13, 2024 | 2.039 |
| March 12, 2024 | 2.015 |
| March 11, 2024 | 1.994 |
| March 08, 2024 | 2.034 |
| March 07, 2024 | 2.048 |
| March 06, 2024 | 2.021 |
| March 05, 2024 | 2.022 |
| March 04, 2024 | 2.007 |
| March 01, 2024 | 2.016 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4763
Minimum
Aug 15 2019
2.530
Maximum
May 10 2024
1.112
Average
1.064
Median
Apr 28 2022
Price to Book Value Benchmarks
| Viatris Inc | 0.6475 |
| Alvotech | -- |
| AstraZeneca PLC | 6.392 |
| Corcept Therapeutics Inc | 5.144 |
| GSK PLC | 5.259 |
Price to Book Value Related Metrics
| PS Ratio | 1.142 |
| Price to Free Cash Flow | 20.81 |
| Price | 16.26 |
| Earnings Yield | -2.52% |
| Market Cap | 18.41B |
| Operating PE Ratio | 5.493 |
| Normalized PE Ratio | 8.441 |